Aspire-Lakewood Holdings, Inc. (ASBP)

Aspire-Lakewood Holdings, Inc. develops nanotechnology-based sublingual delivery systems designed to improve the absorption of drugs, supplements and nutraceuticals taken under the tongue. Its lead pharmaceutical candidate is a sublingual high-dose aspirin formulation intended for pain management and anti-inflammatory use.

Through its acquisition of Dura Driver Control Systems, the company also manufactures automotive and industrial control systems. Formerly known as Aspire Biopharma Holdings, the company adopted its current name in 2026. It is based in Estero, Florida, and its common stock trades on Nasdaq.